EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reactivating Hippo by drug compounds to suppress gastric cancer and enhance chemotherapy sensitivity

Zhifa Cao, Yu Hou, Zhangting Zhao, Hui Zhang, Luyang Tian, Yiming Zhang, Chao Dong, Fenghua Guo, Lijie Tan, Yi Han, Wenjia Wang, Shi Jiao und 3 weitere

Journal of Biological Chemistry · 2024-06 · 300 (6) · 107311

DOI: 10.1016/j.jbc.2024.107311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024-06. Verfasst von Zhifa Cao und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Stomatolog…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Protein Serine-Threonine Kinases, Hippo Signaling Pathway, Disulfiram. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, Fundamental Research Funds for the Central Universities, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Hippo signaling pathway plays an essential role in organ size control and tumorigenesis. Loss of Hippo signal and hyper-activation of the downstream oncogenic YAP signaling are commonly observed in various types of cancers. We previously identified STRN3-containing PP2A phosphatase as a negative regulator of MST1/2 kinases (i.e., Hippo) in gastric cancer (GC), opening the possibility of selectively targeting the PP2Aa-STRN3-MST1/2 axis to recover Hippo signaling against cancer. Here, we further discovered 1) disulfiram (DSF), an FDA-approved drug, which can similarly block the binding of STRN3 to PP2A core enzyme and 2) CX-6258 (CX), a chemical inhibitor, that can disrupt the interaction between STRN3 and MST1/2, both allowing reactivation of Hippo activity to inhibit GC. More importantly, we found these two compounds, via an MST1/2 kinase-dependent manner, inhibit DNA repair to sensitize GC towards chemotherapy. In addition, we identified thiram, a structural analog of DSF, can function similarly to inhibit cancer cell proliferation or enhance chemotherapy sensitivity. Interestingly, inclusion of copper ion enhanced such effects of DSF and thiram on GC treatment. Overall, this work demonstrated that pharmacological targeting of the PP2Aa-STRN3-MST1/2 axis by drug compounds can potently recover Hippo signal for tumor treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsProtein Serine-Threonine KinasesHippo Signaling PathwayDisulfiramHumansCell Line, TumorAnimalsAntineoplastic AgentsSignal TransductionMiceDrug Resistance, NeoplasmCell ProliferationHepatocyte Growth FactorProtein Phosphatase 2

Stichwörter der Autor:innen

Hippo signalingSTRIPAKchemotherapydrug compoundgastric cancer

Substanzen

Protein Serine-Threonine KinasesDisulfiramAntineoplastic AgentsHepatocyte Growth FactorProtein Phosphatase 2

Autor:innen und Institutionen

  • State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Stomatology, Department of Medical Ultrasound, Shanghai Tenth People's Hospital,…
  • State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Stomatology, Department of Medical Ultrasound, Shanghai Tenth People's Hospital, Tongji University Cancer Center, School of Medicine, Tongji University, Shanghai, China.
  • Department of Medical Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Department of General Surgery, Hua'shan Hospital, Fudan University Shanghai Medical College, Shanghai, China.
  • Department of Thoracic Surgery, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • Fundamental Research Funds for the Central Universities
  • National Key Research and Development Program of China
  • Ministry of Science and Technology of the People's Republic of China
  • National Natural Science Foundation of China

Zitieren

APA

Cao, Z., Hou, Y., Zhao, Z., Zhang, H., Tian, L., Zhang, Y., Dong, C., Guo, F., Tan, L., Han, Y., Wang, W., Jiao, S., Tang, Y., An, L., & Zhou, Z. (2024). Reactivating Hippo by drug compounds to suppress gastric cancer and enhance chemotherapy sensitivity. Journal of Biological Chemistry, 300(6), 107311. https://doi.org/10.1016/j.jbc.2024.107311

Vancouver

Cao Z, Hou Y, Zhao Z, Zhang H, Tian L, Zhang Y, et al. Reactivating Hippo by drug compounds to suppress gastric cancer and enhance chemotherapy sensitivity. Journal of Biological Chemistry. 2024;300(6):107311. doi:10.1016/j.jbc.2024.107311

BibTeX
@article{Cao2024,
  author = {Cao, Zhifa and Hou, Yu and Zhao, Zhangting and Zhang, Hui and Tian, Luyang and Zhang, Yiming and Dong, Chao and Guo, Fenghua and Tan, Lijie and Han, Yi and Wang, Wenjia and Jiao, Shi and Tang, Yang and An, Liwei and Zhou, Zhaocai},
  title = {Reactivating Hippo by drug compounds to suppress gastric cancer and enhance chemotherapy sensitivity},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  volume = {300},
  number = {6},
  pages = {107311},
  doi = {10.1016/j.jbc.2024.107311}
}
Kostenlos starten →